Why DePuy Synthes’ Gemtrack deal could reshape navigation in hip, knee and shoulder surgery
DePuy Synthes wants to remove a robotics bottleneck. Its Gemtrack deal could change joint surgery navigation if regulators agree.
Johnson & Johnson clears a key OTTAVA hurdle, but the harder robotics test comes next
Robotic surgery is opening up. Johnson & Johnson’s OTTAVA data may test whether hospitals want a new soft tissue platform.